SHANK3 and Phelan-McDermid syndrome: Prenatal HDAC inhibition by VPA transiently reduces the expression of Shank3 14 days after culturing embryonic neurons [263], which suggests the presence of a compensatory mechanism that reduces the genetic load for ASD, in contrast to the strong impact of  Shank3 mutations in Phelan-McDermid syndrome.